D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 100 Citations 34,610 514 World Ranking 4941 National Ranking 2761

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His primary areas of study are Pathology, Immunohistochemistry, Sarcoma, Cancer research and Carcinoma. The various areas that Jason L. Hornick examines in his Pathology study include Solitary fibrous tumor, Anatomy and CD117. His study in Immunohistochemistry is interdisciplinary in nature, drawing from both Gene rearrangement, GiST, PDGFRA, CD34 and Anaplastic lymphoma kinase.

Ewing's sarcoma is closely connected to Dermatofibrosarcoma protuberans in his research, which is encompassed under the umbrella topic of Sarcoma. His Cancer research research incorporates elements of Fusion gene, Germline mutation, Transcription factor and DNA repair. His Carcinoma study combines topics from a wide range of disciplines, such as Chromatin remodeling, SMARCB1, SOX2, Neuroendocrine tumors and Breast cancer.

His most cited work include:

  • Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. (580 citations)
  • Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. (555 citations)
  • Inflammatory myofibroblastic tumours: where are we now? (459 citations)

What are the main themes of his work throughout his whole career to date?

Pathology, Immunohistochemistry, Internal medicine, Cancer research and Sarcoma are his primary areas of study. His Differential diagnosis, Soft tissue, Biopsy, Epithelioid cell and Synovial sarcoma study are his primary interests in Pathology. Jason L. Hornick has included themes like Fluorescence in situ hybridization, Staining, Carcinoma and Antibody in his Immunohistochemistry study.

The Internal medicine study combines topics in areas such as Gastroenterology and Oncology. Jason L. Hornick is studying PDGFRA, which is a component of Cancer research. His research integrates issues of Solitary fibrous tumor and Malignant peripheral nerve sheath tumor in his study of Sarcoma.

He most often published in these fields:

  • Pathology (60.49%)
  • Immunohistochemistry (25.90%)
  • Internal medicine (19.66%)

What were the highlights of his more recent work (between 2018-2021)?

  • Pathology (60.49%)
  • Immunohistochemistry (25.90%)
  • Cancer research (20.04%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Pathology, Immunohistochemistry, Cancer research, Internal medicine and Sarcoma. His Fusion gene research extends to the thematically linked field of Pathology. He has researched Immunohistochemistry in several fields, including Fluorescence in situ hybridization, Staining and Antibody.

His Cancer research research is multidisciplinary, relying on both Gene rearrangement, Immune system, Leiomyosarcoma, Receptor tyrosine kinase and CDKN2A. Jason L. Hornick interconnects Gastroenterology, Exome sequencing and Oncology in the investigation of issues within Internal medicine. The concepts of his Sarcoma study are interwoven with issues in Perivascular Epithelioid Cell Tumors, Solitary fibrous tumor, Malignant peripheral nerve sheath tumor and Sirolimus.

Between 2018 and 2021, his most popular works were:

  • Neuropathological Features of Covid-19. (241 citations)
  • In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19. (97 citations)
  • Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs (62 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

His scientific interests lie mostly in Pathology, Immunohistochemistry, Sarcoma, Internal medicine and Cancer research. His work in the fields of Pathology, such as Autopsy, intersects with other areas such as Spindle cell rhabdomyosarcoma. His Immunohistochemistry research includes elements of Fluorescence in situ hybridization, Staining and Antibody.

His Sarcoma research focuses on Solitary fibrous tumor and how it relates to Soft tissue, Malignant peripheral nerve sheath tumor, Nasopharyngeal angiofibroma, Infantile Fibrosarcoma and Dermatofibrosarcoma protuberans. His Internal medicine research integrates issues from Gastroenterology, Cluster of differentiation and Oncology. His research in Cancer research intersects with topics in Spiradenoma, Missense mutation, Spiradenocarcinoma and Cylindroma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.

Cheryl M Coffin;Jason L Hornick;Christopher D M Fletcher.
The American Journal of Surgical Pathology (2007)

885 Citations

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

James E. Butrynski;David R. D’Adamo;Jason L. Hornick;Paola Dal Cin.
The New England Journal of Medicine (2010)

824 Citations

Inflammatory myofibroblastic tumours: where are we now?

Briana Gleason;Jason Hornick.
Journal of Clinical Pathology (2008)

709 Citations

KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.

Fabiola Medeiros;Christopher L Corless;Anette Duensing;Jason L Hornick.
The American Journal of Surgical Pathology (2004)

662 Citations

Neuropathological Features of Covid-19.

Isaac H. Solomon;Erica Normandin;Shamik Bhattacharyya;Shibani S. Mukerji.
The New England Journal of Medicine (2020)

604 Citations

Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations

Katherine A. Janeway;Su Young Kim;Maya Lodish;Vânia Nosé.
Proceedings of the National Academy of Sciences of the United States of America (2011)

598 Citations

Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics

Leona A. Doyle;Marina Vivero;Christopher D. M. Fletcher;Fredrik Mertens.
Modern Pathology (2014)

570 Citations

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

Adam Abeshouse;Clement Adebamowo;Sally N. Adebamowo;Rehan Akbani.
Cell (2017)

561 Citations

Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma

Jason L. Hornick;Paola Dal Cin;Christopher D.M. Fletcher.
The American Journal of Surgical Pathology (2009)

536 Citations

A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.

Mari Mino-Kenudson;Lucian R. Chirieac;Kenny Law;Jason L. Hornick.
Clinical Cancer Research (2010)

528 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jason L. Hornick

Cristina R. Antonescu

Cristina R. Antonescu

Memorial Sloan Kettering Cancer Center

Publications: 100

Christopher D.M. Fletcher

Christopher D.M. Fletcher

Brigham and Women's Hospital

Publications: 91

Anthony J. Gill

Anthony J. Gill

University of Sydney

Publications: 88

Jorge S. Reis-Filho

Jorge S. Reis-Filho

Memorial Sloan Kettering Cancer Center

Publications: 80

Alexander J. Lazar

Alexander J. Lazar

The University of Texas MD Anderson Cancer Center

Publications: 75

Cyril Fisher

Cyril Fisher

Royal Marsden NHS Foundation Trust

Publications: 68

Andrew L. Folpe

Andrew L. Folpe

Mayo Clinic

Publications: 63

Alessandro Gronchi

Alessandro Gronchi

University of Milan

Publications: 56

Markku Miettinen

Markku Miettinen

National Cancer Institute

Publications: 51

Michal Michal

Michal Michal

Charles University

Publications: 51

Yoshinao Oda

Yoshinao Oda

Kyushu University

Publications: 49

Christopher L. Corless

Christopher L. Corless

Oregon Health & Science University

Publications: 48

Michael Heinrich

Michael Heinrich

Oregon Health & Science University

Publications: 47

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 47

Brian P. Rubin

Brian P. Rubin

Cleveland Clinic

Publications: 46

Robert G. Maki

Robert G. Maki

University of Pennsylvania

Publications: 46

Trending Scientists

Rudolf Gorenflo

Rudolf Gorenflo

Freie Universität Berlin

Andre Seyfarth

Andre Seyfarth

Technical University of Darmstadt

Philipp Mayer

Philipp Mayer

Technical University of Denmark

Celso Valentim Santilli

Celso Valentim Santilli

Sao Paulo State University

Johannes von Lintig

Johannes von Lintig

Case Western Reserve University

Erich Gulbins

Erich Gulbins

University of Duisburg-Essen

Michal Pravenec

Michal Pravenec

Czech Academy of Sciences

Nikolaus Froitzheim

Nikolaus Froitzheim

University of Bonn

James H. Swift

James H. Swift

University of California, San Diego

Chao Luo

Chao Luo

University of California, Santa Barbara

Pedro Romero

Pedro Romero

University of Lausanne

Charles C. Miller

Charles C. Miller

The University of Texas Health Science Center at Houston

Thomas G. Pickering

Thomas G. Pickering

Columbia University

Marc J. van de Vijver

Marc J. van de Vijver

University of Amsterdam

Merrill Singer

Merrill Singer

University of Connecticut

Adrian Jenkins

Adrian Jenkins

Durham University

Something went wrong. Please try again later.